Artificial intelligence news and machine learning news

In Depth 7 Jun 2021

The Post-Covid Future of AI for Drug Development

With the global Covid-19 outbreak in early 2020, pharma companies and biotechs have increasingly turned to artificial intelligence to improve precision and speed in drug development. Artificial intelligence (AI), the ability of machines to learn from new input, is a broad term for a range of computing methods. Recommendation engines used by online shopping or […]

June 7, 2021 - 11 minutesmins - By Matthew Williams

Best in Biotech 19 Oct 2020

Top 10 Companies Combining AI and Drug Discovery in Europe

Rapid advances in artificial intelligence over the last decade have the potential to revolutionize how drugs are developed. These are the top 10 companies in Europe that are working to make AI drug discovery a reality. Drug development is a slow and increasingly expensive process. Artificial intelligence (AI) has the potential to make the drug […]

October 19, 2020 - 8 minutesmins - By Helen Albert

In Depth 22 Jul 2020

Artificial Intelligence: A Superpower in the Fight Against Covid-19

The rapid spread of Covid-19 around the world has left drug developers with limited time to identify drug candidates to fight the virus. Amid this crisis, artificial intelligence has proven its value as a tool to make drug discovery faster and cost-effective. Drug discovery is an expensive, long-winded process. Taking a drug from discovery to […]

July 22, 2020 - 8 minutesmins - By David Kirk

News and Trends 29 May 2020

AI Drug Discovery Firm Exscientia Closes €54M Series C

UK-based Exscientia has closed a Series C financing round of €54M ($60M) to develop its artificial intelligence (AI) technology to guide drug discovery. The Danish investor Novo Holdings led the round with its first investment in the company. Additional funding also came from existing investors including drug development company Evotec and Chinese VC firm GT […]

May 29, 2020 - 3 minutesmins - By David Kirk

genomics machine learning personalized medicine

News and Trends 8 May 2020

€7M Series A To Democratize Genomics with AI-Driven Cloud Software

The UK-based bioinformatics firm Lifebit Biotech has closed a €7M Series A funding round, which will help the startup to accelerate the global market expansion of its AI-driven, cloud-based genomics analysis software. The round was led by the Parisian VC firm Idinvest Partners and also included returning investors Pentech Ventures, Beacon Capital, and Connect Ventures. […]

May 8, 2020 - 3 minutesmins - By Laura Cowen

neurofibromatosis healx ai drug repurposing

News and Trends 15 Apr 2020

Healx Deploys AI Drug Discovery Technology Against Rare Nerve Disease

The AI-driven drug repurposing company Healx has teamed up with the global Children’s Tumor Foundation (CTF) to develop new treatments for the genetic disease neurofibromatosis type 1, right after the FDA approved the first-ever drug for the condition. In the collaboration, the UK biotech will use its AI-driven pharmacology expertise to speed a candidate drug […]

April 15, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 3 Apr 2020

UK-US Initiative to Screen Drugs Using AI for Coronavirus Treatments

The UK company Exscientia will use its AI-driven drug discovery platform to examine a collection of 15,000 potential coronavirus disease treatments in collaboration with the US research institute Calibr and the non-profit synchrotron company Diamond Light Source. The team’s huge collection of drug molecules will be provided by Calibr, part of the US medical institute […]

April 3, 2020 - 4 minutesmins - By David Kirk

novadiscovery in silico clinical trial ai

Startup Scout 14 Feb 2020

Novadiscovery Carries out Clinical Trials using AI and Simulations

Novadiscovery, based in Lyon, France, is developing AI-based simulation technology to predict clinical trial outcomes and cut their running costs. Mission: To predict the outcomes of clinical trials in silico using a combination of artificial intelligence (AI) and computational models of the biology underlying the disease. Clinical trials cost the healthcare industry billions of euros […]

February 14, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 13 Feb 2020

French Partnership Deploys AI for Antibody Drug Discovery

French companies OSE Immunotherapeutics and MAbSilico are teaming up to drive the discovery of new antibody drugs using artificial intelligence. The three-year partnership will use artificial intelligence, or AI, in six programs designed to accelerate the development of therapeutic monoclonal antibodies (mAbs) that can target cancer and autoimmune diseases. AI can improve the efficiency of […]

February 13, 2020 - 2 minutesmins - By External Contributor

News and Trends 4 Feb 2020

Swiss Biotech Raises €16M to Treat Autism Spectrum Disorder

Stalicla has bagged €16.3M in a Series A round to test drugs repurposed using AI for the treatment of autism spectrum disorder in phase I. The round consists of a recent €7M (CHF 7.7M) closing and an initial first tranche of €9.3M (CHF 10M) raised last year. The investors in the latest closing were not […]

February 4, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 31 Jan 2020

AI-Designed Drug Enters Phase I to Treat OCD

A drug designed by the UK firm Exscientia using AI-powered software has entered into a phase I clinical trial for the treatment of obsessive-compulsive disorder, commonly known as OCD. The clinical development of the drug will be carried out by Sumitomo Dainippon Pharma, Exscientia’s Japanese collaborator. The drug took just 12 months to get to […]

January 31, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 5 Nov 2019

UK Scientists Speed up Brain Cancer Diagnosis with AI

A technique combining a blood test with artificial intelligence (AI), developed by the UK company ClinSpec Diagnostics, could help to prioritize which patients need to be scanned for brain cancer. A team led by researchers at the University of Strathclyde and the University of Edinburgh, UK, trialed the technology on blood samples from 400 people […]

November 5, 2019 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Artificial intelligence

The Post-Covid Future of AI for Drug Development

Top 10 Companies Combining AI and Drug Discovery in Europe

Artificial Intelligence: A Superpower in the Fight Against Covid-19

AI Drug Discovery Firm Exscientia Closes €54M Series C

€7M Series A To Democratize Genomics with AI-Driven Cloud Software

Healx Deploys AI Drug Discovery Technology Against Rare Nerve Disease

UK-US Initiative to Screen Drugs Using AI for Coronavirus Treatments

Novadiscovery Carries out Clinical Trials using AI and Simulations

French Partnership Deploys AI for Antibody Drug Discovery

Swiss Biotech Raises €16M to Treat Autism Spectrum Disorder

AI-Designed Drug Enters Phase I to Treat OCD

UK Scientists Speed up Brain Cancer Diagnosis with AI

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!